Company intelligence / Profile preview

ImperialOel

Hamburg, Germany

Ownership: Private
Development stage: Other

Overview

ImperialOel produces and supplies commercial-scale pharmaceutical-grade lanolin, natural lipids, and omega-3 ingredients for infant formula, nutritional supplements, cosmetics, pharmaceuticals, and specialty industrial uses. The company is recognized as a leading independent supplier of DHA omega-3 for infant formula and baby food, with activities spanning product customization, formulation support, and regulatory guidance.

Therapeutic areas: Metabolic DisordersDermatologyOther
Modalities: Small moleculeNatural lipidOilOmega-3 fatty acidLanolin and derivatives
Industry: Chemicals & Materials

Partnerships

Extensive manufacturing partnerships across Europe and Asia, including direct sourcing from sheep farmers and processors for sustainability

Beyond the preview

Go deeper on ImperialOel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImperialOel.

Explore the full profile